Literature DB >> 11238305

Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry.

J M Lacey1, H R Bergen, M J Magera, S Naylor, J F O'Brien.   

Abstract

BACKGROUND: Congenital disorders of glycosylation (CDG) are autosomal recessive disorders that produce increased serum carbohydrate-deficient transferrin (CDT) isoforms. Methods to resolve CDT from fully glycosylated transferrin (Trf) have been based on a neutral shift in the isoelectric focusing (IEF) pattern or on a reduction in the negative charge, allowing resolution by anion-exchange chromatography. Our purpose was to develop a method of resolution and relative quantification of Trf isoforms using online immunoaffinity liquid chromatography-mass spectrometry (LC-MS).
METHODS: Serum (25 microL) was diluted with 100 microL of water before application to an immunoaffinity column that sequestered Trf isoforms. Trf isoforms were eluted from the immunoaffinity column, concentrated on a C4 column, eluted from the C4 column, and introduced into the mass spectrometer. Analysis of the Trf isoforms was entirely automated and completed in <10 min per sample.
RESULTS: The LC-MS method demonstrated that the major abnormal Trf isoforms in CDG lack one complete oligosaccharide structure (mono-oligosaccharide) or both oligosaccharide structures (a-oligosaccharide), but not the sialic acids, as presumed on the basis of IEF methods. Calculation of relative ratios among three possible species (mono-/di-oligosaccharide and a-/di-oligosaccharide) is reproducible [mean intra- and interassay CVs were 9.3% (n = 10) and 10% (n = 5), respectively]. A reference range for patients <18 years was determined by analysis of 209 samples (for mono-/di-oligosaccharide, the median was 0.041 and the range was 0.018-0.083; for a-/di-oligosaccharide, the median was 0.007 and the range was 0.002-0.036). Comparison of data obtained with an affinity chromatography-IEF method and the LC-MS method demonstrated equivalence in the interpreted results (n = 170).
CONCLUSIONS: Advantages of the LC-MS method include improved sensitivity, minimal sample preparation, and an analysis time of <10 min. The method was automated, which allowed high throughput, with >100 samples analyzed in a single day. Moreover, the nature of the oligosaccharide defect in CDG is accurately reflected by mass resolution, and subtle oligosaccharide truncations may also be detected by this method.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238305

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  51 in total

Review 1.  New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system.

Authors:  Bradley S Miller; Hudson H Freeze
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometry.

Authors:  Yuhong Chen; Melissa R Snyder; Yi Zhu; Linda J Tostrud; Linda M Benson; Jerry A Katzmann; H Robert Bergen
Journal:  Clin Chem       Date:  2011-06-02       Impact factor: 8.327

3.  Stabilization of hypoglycosylation in a patient with congenital disorder of glycosylation type Ia.

Authors:  S H Hahn; S J Minnich; J F O'Brien
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Electrospray ionisation mass spectrometry: principles and clinical applications.

Authors:  C S Ho; C W K Lam; M H M Chan; R C K Cheung; L K Law; L C W Lit; K F Ng; M W M Suen; H L Tai
Journal:  Clin Biochem Rev       Date:  2003

5.  Mutations in the translocon-associated protein complex subunit SSR3 cause a novel congenital disorder of glycosylation.

Authors:  Bobby G Ng; Charles M Lourenço; Marie-Estelle Losfeld; Kati J Buckingham; Martin Kircher; Deborah A Nickerson; Jay Shendure; Michael J Bamshad; Hudson H Freeze
Journal:  J Inherit Metab Dis       Date:  2019-04-16       Impact factor: 4.982

Review 6.  Mass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.

Authors:  Olgica Trenchevska; Randall W Nelson; Dobrin Nedelkov
Journal:  Bioanalysis       Date:  2016-07-11       Impact factor: 2.681

7.  A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.

Authors:  Wenyue Zhang; Philip M James; Bobby G Ng; Xueli Li; Baoyun Xia; Jiang Rong; Ghazia Asif; Kimiyo Raymond; Melanie A Jones; Madhuri Hegde; Tongzhong Ju; Richard D Cummings; Katie Clarkson; Tim Wood; Cornelius F Boerkoel; Hudson H Freeze; Miao He
Journal:  Clin Chem       Date:  2015-10-01       Impact factor: 8.327

8.  PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia.

Authors:  Asbjørg Stray-Pedersen; Paul H Backe; Hanne S Sorte; Lars Mørkrid; Niti Y Chokshi; Hans Christian Erichsen; Tomasz Gambin; Katja B P Elgstøen; Magnar Bjørås; Marcin W Wlodarski; Marcus Krüger; Shalini N Jhangiani; Donna M Muzny; Ankita Patel; Kimiyo M Raymond; Ghadir S Sasa; Robert A Krance; Caridad A Martinez; Shirley M Abraham; Carsten Speckmann; Stephan Ehl; Patricia Hall; Lisa R Forbes; Else Merckoll; Jostein Westvik; Gen Nishimura; Cecilie F Rustad; Tore G Abrahamsen; Arild Rønnestad; Liv T Osnes; Torstein Egeland; Olaug K Rødningen; Christine R Beck; Eric A Boerwinkle; Richard A Gibbs; James R Lupski; Jordan S Orange; Ekkehart Lausch; I Celine Hanson
Journal:  Am J Hum Genet       Date:  2014-06-12       Impact factor: 11.025

9.  Factor VIII and vWF deficiency in STT3A-CDG.

Authors:  Irene J Chang; Heather M Byers; Bobby G Ng; John Lawrence Merritt; Reid Gilmore; Shiteshu Shrimal; Wei Wei; Yuan Zhang; Amanda B Blair; Hudson H Freeze; Bin Zhang; Christina Lam
Journal:  J Inherit Metab Dis       Date:  2019-01-30       Impact factor: 4.982

10.  Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1.

Authors:  Bobby G Ng; Carla G Asteggiano; Martin Kircher; Kati J Buckingham; Kimiyo Raymond; Deborah A Nickerson; Jay Shendure; Michael J Bamshad; Matthias Ensslen; Hudson H Freeze
Journal:  Am J Med Genet A       Date:  2017-08-29       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.